Dr. Martin Mihm, MD
Dermapathologist | Dermatopathology
41 Avenue Louis Pasteur Suite 317 Boston Massachusetts, 02115About
Martin C. Mihm Jr., MD, is a prominent dermatologist currently serving patients as owner and director of Mihm Cutaneous Pathology Consultative Service at Brigham and Women's Hospital in Boston, Massachusetts. Dr. Mihm's expertise covers problematic pigmented lesions, problematic lesions of lymphoma, and problems relating to inflammatory diseases of the skin. He has co-authored hundreds of articles and twelve books concerning skin pathology. While excelling as an academician and clinician, he has also built a busy consultation service. To date, he has consulted on more than 350,000 cases, nationally and worldwide, and continues to offer accurate diagnosis, prognosis, and treatment recommendations on routine and challenging cases in Dermatology/Dermatopathology. Dr. Mihm is a world renowned international consultant for melanoma and other skin tumors, including lymphoma. Furthermore, he serves as Director of the Melanoma Program in Dermatology at the Brigham and Women’s Hospital and Associate Director of Dana-Farber and Brigham and Women’s Cancer Center. After earning his medical degree in 1961 at the University of Pittsburgh School of Medicine, Dr. Mihm completed his internal medicine residency at Mount Sinai, followed by his dermatology residency at Massachusetts General Hospital and his pathology fellowship at Massachusetts General Hospital. He is board-certified by the American Board of Dermatology in dermatology, pathology, and dermatopathology. Furthermore, in order to stay up to date on all medical advancements in his field, he maintains a professional membership with American Academy of Dermatology and the American College of Physicians.
Dr. Martin Mihm, MD's Videos
Education and Training
University of Pittsburgh School of Medicine 1961
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Recognition and evaluation of cytological dysplasia in acquired melanocytic nevi.
- Lentigo maligna and malignant melanoma in situ, lentigo maligna type.
- Desmoplastic malignant melanoma: diagnosis of early clinical lesions.
- Malignant melanoma with prominent pigment synthesis: "animal type" melanoma--a clinical and histological study of six cases with a consideration of other melanocytic neoplasms with prominent pigment synthesis.
- Pseudolymphoma syndrome due to carbamazepine.
- Tools of the trade: statistical analysis in dermatopathology articles.
- Detection of microscopic melanoma metastases in sentinel lymph nodes.
- Melanocytic matricoma: a report of two cases of a new entity.
- Symmetrical hemorrhagic bullae in an immunocompromised host.
- GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas.
- Warty (condylomatous) squamous cell carcinoma of the penis: a report of 11 cases and proposed classification of 'verruciform' penile tumors.
- Bullous dermatosis of hemodialysis.
- Microphthalmia transcription factor expression in cutaneous benign, malignant melanocytic, and nonmelanocytic tumors.
- Thin melanomas.
- Melanoma associated with blue nevus and melanoma mimicking cellular blue nevus: a clinicopathologic study of 10 cases on the spectrum of so-called 'malignant blue nevus'.
Areas of expertise and specialization
Faculty Titles & Positions
- Director The Mihm Cutaneous Pathology Consultative Service -
- Director of the Melanoma Program Department of Dermatology at Brigham and Women’s Hospital -
- Associate Director of the Center for Melanoma Oncology Dana-Farber/Brigham and Women’s Cancer Center -
- Co-Director of the Melanoma Risk and Prevention Clinic Dana-Farber/Brigham and Women’s Cancer Center -
- Professor of Dermatology Harvard Medical School -
Professional Memberships
- American Academy of Dermatology
- American College of Physicians
Fellowships
- Massachusetts General Hospital Pathology 1972
Dr. Martin Mihm, MD's Practice location
Boston, Massachusetts 02115Get Direction
Dr. Martin Mihm, MD's reviews
Write ReviewPatient Experience with Dr. Mihm
Media Releases
Get to know Dermatologist Dr. Martin C. Mihm, Jr., who serves patients in Boston, Massachusetts.
Dr. Mihm Jr. is a world-renowned international consultant for melanoma and skin tumors, including lymphoma, pigmented lesions, and cutaneous inflammatory diseases. He is the Director of The Mihm Cutaneous Pathology Consultative Service, which is a second opinion dermatopathology service affiliated with Brigham and Women’s Hospital.
The services that he offers include: second opinion consultation, clinical and treatment advice, and recommendations.
In his current capacity, he also serves as: Director of the Melanoma Program within the Department of Dermatology at Brigham and Women’s Hospital; Associate Director of the Center for Melanoma Oncology at Dana-Farber/Brigham and Women’s Cancer Center; Co-Director of the Melanoma Risk and Prevention Clinic at Dana-Farber/Brigham and Women’s Cancer Center; and Professor of Dermatology at Harvard Medical School.
Regarding his educational background, Dr. Mihm Jr. started his medical career by earning his medical degree from the University of Pittsburgh School of Medicine. He then went on to complete multiple residencies at top educational venues such as The Mount Sinai Hospital, Montefiore Hospital, the University of Pittsburgh Medical Center, and Massachusetts General Hospital. He also completed a fellowship in pathology at Massachusetts General Hospital in 1972.
Bringing over 30 years of expertise to his field, he is triple board-certified in dermatology, anatomic pathology, and dermatopathology. He is also a Fellow of the American Cancer Society as well as a member of the American Academy of Dermatology and the American College of Physicians.
While excelling, as an academician and clinician, Dr. Mihm Jr. has built a busy consultation service. To date, he has consulted on more than 350.000 cases, nationally and worldwide, and continues to offer accurate diagnosis, prognosis, and treatment recommendations on routine and challenging cases in dermatology/dermatopathology.
He began his melanoma studies with Dr. Wallace Clark in 1965 and co-authored the first publication of the classification of malignant melanoma into subtypes. He also contributed to establishing the importance of tumor infiltrating lymphocytes as an important prognostic factor in primary and metastatic melanoma. Through collaborations with other prominent researchers, his efforts led to the discovery of the role of basophils in human hypersensitivity reactions, and to the first description of the role of the vasculature in human allograft rejection. He also participated in the study of vaccine reactions to autologous melanoma cells and contributed to the description of various factors affecting the host reaction and their relationship to survival. Other notable contributions include the study of vascular anomalies, where the discovery of a specific phenotype in infantile hemangiomas has led to extensive studies on pathogenesis of these lesions.
Dermatology is the branch of medicine dealing with the skin, the largest organ of the body; a specialty with medical, surgical and cosmetic aspects. A dermatologist is a specialist doctor who manages skin diseases due to both internal and external causes and is trained to address cosmetic concerns involving the skin. Dermatological duties include diagnosis and management of a variety of skin disorders, rashes, birthmarks, skin cancer screening and treatment, skin infections, cutaneous surgery and the use of injectables and lasers for skin rejuvenation.
Throughout his career, Dr. Mihm Jr. balanced teaching, research, and excellent clinical service in the field of dermatopathology. He has written over four hundred articles and authored and co-authored twelve books.
Outside of practicing medicine, he enjoys listening to classical music. His favorite professional publication is The New England Journal of Medicine.
Recommended Articles
- Is Skin Cancer Fatal?
Unlike what most people think, skin cancer, like most other cancers, is fatal. Skin cancer is the most common form of cancer in many countries, including the United States. More than 5 million skin cancer cases come up each year. Over 3 million of these cases are found in the United States. In fact,...
- Don't Be a Flake: Tips for Dry Skin
What is dry skin?Dry skin is one of the most common skin problems, and can cause discomfort and embarrassment. Dry skin may look red and flaky and feel tight or painful. It can also cause intense itching, which can disrupt sleep. Often, dry skin is a symptom of some underlying medical issue that...
- Purpura
PurpuraPurpura refers to purple-colored spots that are usually seen on the skin, including mucous membranes and other organs. It is also called skin hemorrhages or blood spots.Purpura is usually recognized when there is pooling of blood under the skin due to ruptured small blood vessels. The size of...
- What are the Benefits of a Facial Serum?
We have heard of adding facial serum to our daily routine to make skin glowing and to keep aging at bay.What are face serums and what are their benefits? Facial serums are fast-absorbing liquids meant to provide nutrients deeper into the skin than normal creams and lotions. It is used either in...
- Common Acne Myths
Severe acne can have a significant impact on one’s life, as well as with social relationships. It can affect a person’s self confidence and self-esteem, which can lead to depression in time. This is particularly true of teenagers and young adults.Acne can cause social phobia, fear of being...
- Using Sunscreen Does Not Guarantee Full Protection
According to a new study, people who apply sunscreen regularly and vigilantly may have more painful and damaging sunburns. In this study, the researchers collected data regarding the different methods of shielding the sun, and the effectiveness of each of these methods. Data was collected from more...